drugset / Trial / NCT07285291
A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
RandomizedParallel-groupTriple-blindTreatment
Summary
A phase 3, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis
Timeline
- Start
- 2026-01-09
- Primary completion
- 2026-12-22
- Completion
- 2026-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TS-172 | Unknown | 20 mg | Oral |
| Subject | TS-172 | Unknown | 60 mg | Oral |